As of December 2024, Evogene has a market cap of $65.39M. This makes Evogene the world's 22310th valuable company by market cap, according to our data. The market capitalization, also known as a stock market cap is a key financial indication. It represents the combined worth of all the outstanding shares of a publicly traded company multiplied by the current stock price. This figure is often used to see how much a company is worth. This figure is often used to see what is the company net worth.
Year | Market Cap | Change |
---|---|---|
2024 | $37.85M | -8.94% |
2023 | $41.57M | 34.14% |
2022 | $30.99M | -58.42% |
2021 | $74.53M | -65.19% |
2020 | $214.09M | 193.76% |
2019 | $72.88M | -32.44% |
2018 | $107.88M | -31.15% |
2017 | $156.68M | -42.35% |
2016 | $271.77M | -37.02% |
2015 | $431.50M | -13.87% |
2014 | $500.97M | -46.98% |
2013 | $944.95M | 83.30% |
2012 | $515.53M | 24.02% |
2011 | $415.70M | -26.52% |
2010 | $565.72M | 53.38% |
2009 | $368.83M | 95.59% |
2008 | $188.57M | 63.58% |
2007 | $115.28M | - |